Trading in Redx Pharma shares set to resume
Trading in shares of Cheshire-based drug discovery company Redx Pharma, which carries out research into treatment for cancer and fibrosis, are to resume at noon today (Monday, November 6) after a fove-month hiatus.
This follows the Alderley Park-headquartered company’s exit from administration.
In a letter to shareholders AIM-listed Redx said it had “sufficient working capital to return to the stock market as ‘a going concern’, with the administrators, FRP, having reached agreement with all outstanding creditors”.
I... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...
